Glucogenesis is a shorthand term that typically refers to gluconeogenesis, the metabolic process your body uses to make brand-new glucose from non-sugar sources. When blood sugar drops between meals or during a fast, your liver (and to a lesser extent your kidneys) converts molecules like lactate, amino acids, and glycerol into glucose to keep your brain, red blood cells, and muscles fueled. It is one of the most important survival mechanisms in human metabolism.
The term is sometimes confused with glycogenesis, which is a different process: the storage of glucose as glycogen. This article focuses on gluconeogenesis, since that is the process most people are asking about when they search “glucogenesis.”
How Gluconeogenesis Differs From Related Processes
Three glucose-related pathways have similar-sounding names, and mixing them up is easy. Gluconeogenesis creates new glucose molecules from scratch, using raw materials that are not sugars. Glycogenesis packages existing glucose into glycogen, a starch-like storage molecule held mainly in the liver and muscles. Glycogenolysis does the reverse: it breaks glycogen back down to release glucose when energy is needed quickly.
These three processes work together like a supply chain. After a meal, excess glucose is stored as glycogen (glycogenesis). Between meals, glycogen stores are tapped first (glycogenolysis). Once those stores run low, typically after several hours of fasting, gluconeogenesis ramps up and becomes the dominant source of blood glucose.
Where It Happens in the Body
The liver handles the bulk of gluconeogenesis under normal conditions. But the kidneys play a larger role than scientists once thought. During an overnight fast, the kidneys contribute roughly 28% of the body’s new glucose production. Under stress, acidosis, or prolonged fasting, that share can rise to 40 to 50%, making the kidneys the second most important organ for this process. Within the kidney, gluconeogenesis occurs specifically in the outer layer (the cortex), in cells lining a structure called the proximal tubule, which is the only kidney segment equipped with the necessary enzymes.
What Your Body Uses to Make Glucose
The raw materials for gluconeogenesis are molecules your body already has on hand from other metabolic activities. The three major ones are lactate, glycerol, and glucogenic amino acids.
- Lactate is produced by muscles during exercise and by red blood cells constantly. The liver recycles it back into glucose in what is sometimes called the Cori cycle.
- Glycerol comes from the breakdown of stored fat (triglycerides). When your body taps fat reserves for energy, the glycerol backbone gets shipped to the liver and converted to glucose.
- Glucogenic amino acids come from protein, either dietary protein or, during prolonged fasting, muscle tissue. Most of the 20 amino acids can feed into gluconeogenesis at various entry points.
Pyruvate and propionate (a short-chain fatty acid produced by gut bacteria) also serve as precursors, though they contribute smaller amounts under typical conditions.
How the Process Works, Step by Step
Gluconeogenesis is essentially glycolysis (the breakdown of glucose) running in reverse, but it cannot simply reverse every step. Four reactions in glycolysis are one-way streets, so the body uses four specialized enzymes to get around them.
The pathway starts with pyruvate, a three-carbon molecule. An enzyme called pyruvate carboxylase adds a carbon group to pyruvate, turning it into a four-carbon intermediate called oxaloacetate. A second enzyme then removes a carbon and adds a phosphate group, converting oxaloacetate into a molecule called PEP. From there, most of the remaining steps use the same enzymes as glycolysis, just running in the opposite direction.
Two more dedicated enzymes handle the final bottlenecks. One removes a phosphate group from a six-carbon sugar intermediate in what is the rate-limiting step of the entire pathway, meaning it controls how fast gluconeogenesis can run. The last enzyme strips a final phosphate group from glucose-6-phosphate to release free glucose into the bloodstream. This final step is critical: it only occurs in the liver and kidneys, which is why those are the only organs that can export newly made glucose for the rest of the body to use.
The whole process is energy-expensive. Converting two molecules of pyruvate into one molecule of glucose costs six high-energy phosphate bonds, a significant investment that reflects how important maintaining blood sugar is for survival.
Hormones That Control the Process
Your body tightly regulates gluconeogenesis through opposing hormones. Insulin, released after eating, puts the brakes on glucose production. In healthy people, a normal rise in insulin after a meal suppresses gluconeogenesis by about 20% and shuts down glycogen breakdown almost completely. This prevents blood sugar from climbing too high when glucose is already arriving from food.
Glucagon works in the opposite direction. Released by the pancreas when blood sugar falls, glucagon activates signaling pathways in the liver that ramp up glucose production. This is the hormone responsible for keeping your blood sugar stable overnight and between meals. Cortisol, the stress hormone, also stimulates gluconeogenesis, which is one reason blood sugar tends to rise during illness, injury, or chronic stress.
The Role in Type 2 Diabetes
Dysregulated gluconeogenesis is one of the central problems in type 2 diabetes. In people with insulin resistance, insulin loses its ability to suppress glucose production in the liver, even after a meal. The result is that the liver keeps pumping out glucose around the clock, contributing to the persistently high blood sugar levels that define the disease.
Several factors drive this overproduction. The liver becomes resistant to insulin’s signal, so glucose output is not properly shut down. Glucagon levels tend to be abnormally high, continuously activating the fasting-mode pathways that tell the liver to make more glucose. Excess circulating fatty acids from stored fat further stimulate the process through pathways that bypass the insulin receptor entirely.
Studies using advanced imaging have confirmed that in people with type 2 diabetes, glycogen breakdown contributes relatively little to excess blood sugar. It is increased gluconeogenesis, not glycogen release, that is the primary source of elevated fasting glucose. This finding has made the enzymes and signaling molecules in the gluconeogenesis pathway important targets for diabetes treatment. The widely prescribed diabetes medication metformin, for example, works in large part by reducing glucose production in the liver.
When Gluconeogenesis Becomes Essential
During a short fast, like the gap between dinner and breakfast, your liver glycogen stores can cover most of your glucose needs. But those stores are limited, holding roughly 80 to 100 grams of glucose. Once they start running low, gluconeogenesis picks up the slack. During extended fasting or very low-carbohydrate diets, it becomes the body’s primary mechanism for maintaining blood sugar.
Your brain consumes about 120 grams of glucose per day under normal conditions, and red blood cells depend on glucose exclusively because they lack the cellular machinery to burn fat. Without gluconeogenesis, blood sugar would plummet dangerously within hours of your last meal. The process also matters during intense exercise, when muscles consume glucose rapidly, and during pregnancy, when the developing fetus draws continuously on the mother’s blood sugar supply.
People with severe liver disease or rare genetic deficiencies in the key gluconeogenesis enzymes can develop life-threatening low blood sugar (hypoglycemia) during fasting, precisely because this pathway fails to maintain adequate glucose output. Similarly, kidney disease can impair the renal contribution to gluconeogenesis, which may partly explain the increased risk of hypoglycemia seen in people with advanced chronic kidney disease who take blood sugar-lowering medications.